Hinge Health Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Revenue	646.34	587.86	390.4	292.73
Revenue Growth (YoY)	49.78%	50.58%	33.37%	-
Cost of Revenue	124.12	119.64	90.5	98.55
Gross Profit	522.22	468.22	299.9	194.18
Selling, General & Admin	674.69	646.46	230.97	214.64
Research & Development	374.98	368.14	100.84	110.06
Total Operating Expenses	1,050	1,015	331.81	324.69
Operating Income	-500.18	-546.37	-31.91	-130.51
Total Non-Operating Income (Expense)	17.98	19.11	20.65	21.97
Pretax Income	66.52	-527.26	-11.26	-108.55
Provision for Income Taxes	0.82	1	0.68	-0.41
Net Income	-575.65	-528.26	-11.93	-108.14
Minority Interest in Earnings	-2.13	-	-	-
Net Income Attributable to Preferred Dividends	-	-104.17	-	-
Net Income to Common	-543.48	-424.09	-11.93	-108.14
Shares Outstanding (Basic)	70	55	14	13
Shares Outstanding (Diluted)	72	55	14	13
Shares Change (YoY)	107.78%	302.55%	4.16%	-
EPS (Basic)	-12.30	-7.77	-0.88	-8.31
EPS (Diluted)	-12.34	-7.77	-0.88	-8.31
Free Cash Flow	208.86	170.73	47.96	-65.89
Free Cash Flow Growth	22.33%	255.97%	-	-
Free Cash Flow Per Share	2.88	3.13	3.54	-5.06
Gross Margin	80.80%	79.65%	76.82%	66.33%
Operating Margin	-77.39%	-92.94%	-8.17%	-44.59%
Profit Margin	-89.06%	-89.86%	-3.06%	-36.94%
FCF Margin	32.31%	29.04%	12.29%	-22.51%
EBITDA	-495.18	-541.24	-25.96	-124.89
EBITDA Margin	-76.61%	-92.07%	-6.65%	-42.66%
EBIT	-500.18	-546.37	-31.91	-130.51
EBIT Margin	-77.39%	-92.94%	-8.17%	-44.59%
Effective Tax Rate	1.23%	-0.19%	-6.01%	0.37%

SEC Filings: 10-K · 10-Q